SPRY icon

ARS Pharmaceuticals
SPRY

Overview Fund Trends Analyst Outlook Journalist POV

62 hedge funds and large institutions have $1.13B invested in ARS Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$405M
2
+$156M
3
+$117M
4
RCM
RA Capital Management
Massachusetts
+$80.7M
5
BC
Boxer Capital
California
+$77.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.07M
27
$3.24M
28
$2.78M
29
$2.72M
30
$2.67M
31
$2.32M
32
$2.21M
33
$2.08M
34
$1.98M
35
$1.87M
36
$1.66M
37
$1.16M
38
$1.16M
39
$1.01M
40
$968K
41
$903K
42
$891K
43
$882K
44
$699K
45
$641K
46
$598K
47
$598K
48
$525K
49
$508K
50
$463K
1
2
3